معرفی
Mark Loeb is a Professor in the Department of Pathology and Molecular Medicine at McMaster University. His research focuses on infectious diseases, vaccine efficacy, antimicrobial resistance, and respiratory infections. He has led numerous clinical trials, including studies on influenza vaccines, mpox prevention, and SARS-CoV-2 transmission. Loeb has received prestigious awards, including the 2025 Lifetime Achievement Award from AMMI Canada.
Key research interests include optimizing vaccine strategies, evaluating non-pharmacological interventions during pandemics, and addressing antibiotic resistance. His work integrates epidemiological analysis, clinical trials, and translational research to improve public health outcomes. Recent projects include the AeroVax phase 2 trial for an inhaled COVID-19 vaccine and studies on vitamin D's role in preventing respiratory infections.
- Grants: Received $300,000 for bird flu research and led a $6.7M trial testing smallpox vaccines against mpox.
- Awards: 2025 AMMI Canada Lifetime Achievement Award.
- Labs/Teams: Collaborates with the Canadian Immunization Research Network (CIRN) and the Serious Outcomes Surveillance (SOS) network.
